Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOTUM | Q6P988 | 2/20 | 0.73 |
| ▸ | CYP19A1 | P11511 | 10/20 | 0.66 |
| ▸ | NPC1 | O15118 | 1/20 | 0.62 |
| ▸ | RAB9A | P51151 | 1/20 | 0.62 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.57 |
| ▸ | HSP90AB1 | P08238 | 2/20 | 0.56 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.55 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL28329957 | 0.92 | NOTUM (0.63) | NOTUMCYP19A1NPC1RAB9AHRH4 | |
| SCHEMBL6980467 | 0.84 | NOTUM (1.00) | NOTUMCYP19A1HSP90AB1KCNMA1HDAC1 | |
| SCHEMBL28863788 | 0.84 | NOTUM (0.71) | NOTUMCYP19A1NPC1RAB9AHRH4 | |
| SCHEMBL12022159 | 0.84 | KCNMA1 (0.69) | CYP19A1NPC1RAB9AHRH4HSP90AB1 | |
| SCHEMBL3103838 | 0.84 | CYP19A1 (0.68) | NOTUMCYP19A1NPC1RAB9AHRH4 | |
| SCHEMBL16831504 | 0.83 | CYP19A1 (0.69) | NOTUMCYP19A1NPC1RAB9AHRH4 | |
| SCHEMBL16206205 | 0.83 | NOTUM (0.73) | NOTUMCYP19A1HSP90AB1HDAC1 | |
| SCHEMBL2820182 | 0.83 | NOTUM (0.73) | NOTUMCYP19A1NPC1RAB9AHDAC1 | |
| SCHEMBL12885309 | 0.83 | NOTUM (0.73) | NOTUMCYP19A1NPC1RAB9AHRH4 | |
| SCHEMBL16206231 | 0.83 | GBA1 (0.60) | NOTUMCYP19A1HRH4KCNMA1HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240117095-A1 | GRIN LENSES MADE BY 3D PRINTING MONOMER-BASED INKS | VADIENT OPTICS, LLC | 2024-04-11 | — | — | US | claimed |
| WO-2024064650-A2 | GRIN LENSES MADE BY 3D PRINTING MONOMER-BASED INKS | VADIENT OPTICS, LLC (US) | 2024-03-28 | — | — | WO | claimed |
| CN-110483220-B | Composite solid propellant and preparation method and treatment method thereof | 北京理工大学 | 2020-08-11 | — | — | CN | claimed |
| CN-110452358-B | Preparation method of triazole-terminated azido polyether | 北京理工大学 | 2020-08-11 | — | — | CN | claimed |
| US-12592537-B2 | Fiber for optical power amplification and/or optical power generation | UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 2026-03-31 | — | — | US | disclosed |
| US-12571105-B2 | Metallic coated substrates | ARMADILLO METAL COATINGS LTD (GB) | 2026-03-10 | — | — | US | disclosed |
| US-20250288970-A1 | SOLID SORBENT MATERIALS FUNCTIONALIZED WITH POLYAMINES HAVING OXYGEN-CONTAINING UNITS SELECTED FROM CARBONYL UNITS, HYDROXYL UNITS, AND COMBINATIONS THEREOF | GE INFRASTRUCTURE TECHNOLOGY LLC | 2025-09-18 | — | — | US | disclosed |
| EP-4616940-A1 | SOLID SORBENT MATERIALS FUNCTIONALIZED WITH POLYAMINES HAVING OXYGEN-CONTAINING UNITS SELECTED FROM CARBONYL UNITS, HYDROXYL UNITS, AND COMBINATIONS THEREOF | GE Vernova Technology GmbH (CH) | 2025-09-17 | — | — | EP | disclosed |
| EP-4601786-A1 | SORBENT COMPOSITIONS, SYSTEMS, AND METHODS | General Electric Technology GmbH (CH) | 2025-08-20 | — | — | EP | disclosed |
| CN-120020618-A | Transparent base material with antiglare layer and composition for antiglare layer | ＡＧＣ株式会社 | 2025-05-20 | — | — | CN | disclosed |
| WO-2024256789-A1 | IN VITRO MODEL OF INFLAMED INTESTINAL BARRIER | UNIVERSITE DE FRANCHE COMTE (FR) | 2024-12-19 | — | — | WO | disclosed |
| US-20240335527-A1 | VACCINE ADJUVANTS, TRANSFECTION REAGENTS, AND METHODS OF USING THE SAME | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2024-10-10 | — | — | US | disclosed |
| US-4137237-A | ANTIHISTAMINES | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1979-01-30 | — | — | US | disclosed |
| US-4137234-A | ANTIHISTAMINES | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1979-01-30 | — | — | US | disclosed |
| US-4070475-A | THIOALKYL-, AMINOALKYL-, AND OXYALKYL- SUBSTITUTED GUANIDINES | SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) | 1978-01-24 | — | — | US | disclosed |
| US-4024271-A | INHIBITORS OF HISTAMINE ACTIVITY | SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) | 1977-05-17 | — | — | US | disclosed |
| US-4022797-A | PHARMACEUTICALS | SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) | 1977-05-10 | — | — | US | disclosed |
| US-4018931-A | INHIBITION OF H-2 HISTAMINE RECEPTORS | SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) | 1977-04-19 | — | — | US | disclosed |
| US-3950333-A | HISTAMINE INHIBITORS, OXYALKYL, THIOALKYL, AMINOALKYL DERIVATIVES | SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) | 1976-04-13 | — | — | US | disclosed |
| US-3950353-A | HISTAMINE INHIBITORS | SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) | 1976-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12571105-B2 | Metallic coated substrates | SOD1, TET1, TST | NOTUM 4498/4885CYP19A1 3359/4885NPC1 4388/4885 |
| US-12592537-B2 | Fiber for optical power amplification and/or optical power generation | SRMS, VEGFA, HCN4 | NOTUM 4555/4885CYP19A1 3398/4885NPC1 3417/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.